Compare StocksPFE vs VTR

Pfizer, Inc. (PFE) vs Ventas, Inc. (VTR): Which Is the Better Buy in 2026?

As of 2026-08-03, PFE is undervalued at $25, with a DCF intrinsic value of $127985960274 and a margin of safety of 100%. VTR is undervalued at $94, with an intrinsic value of $126 and a margin of safety of 26%. Of the two, PFE has the wider margin of safety.

PFE
Pfizer, Inc.
$25.01
VS
VTR
Ventas, Inc.
$93.51

Rewards

PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Trailing P/E of 19.1x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.
VTR
  • Free cash flow has grown at a 14.6% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 2.94 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 1.38 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
VTR
  • Share count has increased by 19% over the past 4 years, diluting existing shareholders.
  • Net debt/EBITDA of 5.3x indicates heavy leverage — it would take over 4 years of EBITDA to pay off net debt.
  • Altman Z-Score of 1.78 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
PFE
VTR
Valuation
$12.38B
Free Cash Flow
$1.49B
N/A
FCF Yield
3.10%
19.09
Trailing P/E
170.02
8.85
Forward P/E
114.50
Quality & Moat
10.19%
ROIC
2.67%
8.31%
ROE
2.01%
74.80%
Gross Margin
39.97%
2.94
PEG Ratio
1.72
Balance Sheet Safety
0.57
Net Debt / Equity
0.84
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
5.34
6.88%
Dividend Yield
2.14%
PFE: 9Ties: 1VTR: 1
PFEVTR

Historical Fundamentals

Learn more →
PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

VTR

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-26.34
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
VTR
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-2.03B
Δ Market Cap
+$18.74B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
PFE
100.0% Margin of Safety
Price is 100.0% below estimated fair value
Current Price: $25.01
Fair Value: $127985960274.09
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
VTR
25.8% Margin of Safety
Price is 25.8% below estimated fair value
Current Price: $93.51
Fair Value: $125.98
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
PFE

What growth rate is the market pricing in at $25?

-14.2%
Market-Implied Owner Earnings Growth
Standard FCF implies -15.0%

The market implies -14.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding -15.0%, reflecting heavy growth investment.

VTR

What growth rate is the market pricing in at $94?

+22.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +17.4%

The market implies +22.6% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +17.4%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
VTR
49/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
VTR
-2.45
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
PFE
Insiders 0.1%Institutions 69.5%Retail & Other 30.4%
No. of Institutional Holders3,661
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
VTR
Insiders 0.5%Institutions 101.6%
No. of Institutional Holders1,372
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises
VTR
1
Buys (3M)
1
Buys (12M)
Total value (12M): $197,025
EMBLER MICHAEL J
Director
$197,025
@ $78.81 · 2026-06-03
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
VTR
1
Sells (3M)
20
Sells (12M)
Total value (12M): $62.21M
RAKOWICH WALTER C.
Director
$103,915
@ $90.20 · 2026-05-14
ROBERTS CAREY SHEA
General Counsel
$3.02M
@ $85.00 · 2026-02-11
CAFARO DEBRA A
Chief Executive Officer
$848,751
@ $82.23 · 2026-02-06
CAFARO DEBRA A
Chief Executive Officer
$801,605
@ $77.66 · 2026-02-02
PROBST ROBERT F.
Chief Financial Officer
$2.31M
@ $77.25 · 2026-01-02
CAFARO DEBRA A
Chief Executive Officer
$797,475
@ $77.26 · 2026-01-02
CAFARO DEBRA A
Chief Executive Officer
$831,419
@ $80.55 · 2025-12-01
BULGARELLI PETER J
Officer
$400,205
@ $80.04 · 2025-11-19
CAFARO DEBRA A
Chief Executive Officer
$3.26M
@ $79.01 · 2025-11-17
PROBST ROBERT F.
Chief Financial Officer
$2.58M
@ $76.77 · 2025-11-12
BULGARELLI PETER J
Officer
$3,028
@ $75.70 · 2025-11-07
BULGARELLI PETER J
Officer
$372,256
@ $75.05 · 2025-11-06
CAFARO DEBRA A
Chief Executive Officer
$2.33M
@ $75.19 · 2025-11-06
CAFARO DEBRA A
Chief Executive Officer
$25.08M
@ $74.22 · 2025-11-03
CAFARO DEBRA A
Chief Executive Officer
$15.66M
@ $71.32 · 2025-10-20
BULGARELLI PETER J
Officer
$322,215
@ $70.14 · 2025-10-01
CAFARO DEBRA A
Chief Executive Officer
$724,986
@ $70.24 · 2025-10-01
BULGARELLI PETER J
Officer
$28,419
@ $70.00 · 2025-09-15
CAFARO DEBRA A
Chief Executive Officer
$699,864
@ $67.80 · 2025-09-02
PROBST ROBERT F.
Chief Financial Officer
$2.03M
@ $68.49 · 2025-08-04
CAFARO DEBRA A
Chief Executive Officer
$695,722
@ $67.40 · 2025-08-01
PROBST ROBERT F.
Chief Financial Officer
$266,960
@ $68.45 · 2025-07-31
PROBST ROBERT F.
Chief Financial Officer
$1.95M
@ $66.29 · 2025-07-21
PROBST ROBERT F.
Chief Financial Officer
$271,454
@ $66.24 · 2025-07-18
CAFARO DEBRA A
Chief Executive Officer
$287,976
@ $65.82 · 2025-07-18
CAFARO DEBRA A
Chief Executive Officer
$1.07M
@ $65.60 · 2025-07-16
PROBST ROBERT F.
Chief Financial Officer
$11.00M
@ $65.36 · 2025-07-14
ROBERTS CAREY SHEA
General Counsel
$1.51M
@ $64.23 · 2025-05-30
PROBST ROBERT F.
Chief Financial Officer
$1.13M
@ $65.22 · 2025-05-27
PROBST ROBERT F.
Chief Financial Officer
$4.50M
@ $64.59 · 2025-05-21
RAKOWICH WALTER C.
Director
$93,026
@ $63.76 · 2025-05-14
CAFARO DEBRA A
Chief Executive Officer
$682,135
@ $66.09 · 2025-05-02
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
PFE
FearGreed
😐Neutral(52/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
VTR
FearGreed
😐Neutral(58/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (52)
VTR
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (58)
View PFE Full AnalysisView VTR Full Analysis

Frequently Asked Questions: PFE vs VTR

Is Pfizer, Inc. or Ventas, Inc. more undervalued in 2026?

Based on our discounted cash flow model, PFE trades at a 100.0% margin of safety (intrinsic value $127985960274 vs. price $25), compared to VTR's 25.8% margin of safety (intrinsic $126 vs. $94).

Which stock has a wider economic moat, Pfizer, Inc. or Ventas, Inc.?

VTR scores 49/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Pfizer, Inc. in financial distress?

PFE's Altman Z-Score of 1.4 places it in the Distress zone, signaling elevated bankruptcy risk. VTR scores 1.8 (Distress zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Pfizer, Inc. or Ventas, Inc.?

PFE earns 10.2% ROIC versus VTR's 2.7%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Pfizer, Inc.'s or Ventas, Inc.'s?

PFE's dividend earns a safety score of 24/100 (Unsafe), compared to VTR's 18/100 (Unsafe). PFE has raised its dividend for 3 consecutive years.

PFE vs VTR: Which Is the Better Buy in 2026? | SafetyMargin.io